JP2009513555A5 - - Google Patents

Download PDF

Info

Publication number
JP2009513555A5
JP2009513555A5 JP2006519892A JP2006519892A JP2009513555A5 JP 2009513555 A5 JP2009513555 A5 JP 2009513555A5 JP 2006519892 A JP2006519892 A JP 2006519892A JP 2006519892 A JP2006519892 A JP 2006519892A JP 2009513555 A5 JP2009513555 A5 JP 2009513555A5
Authority
JP
Japan
Prior art keywords
formula
compound
residue
azide
boron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006519892A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513555A (ja
JP5052132B2 (ja
Filing date
Publication date
Priority claimed from GBGB0316546.1A external-priority patent/GB0316546D0/en
Application filed filed Critical
Publication of JP2009513555A publication Critical patent/JP2009513555A/ja
Publication of JP2009513555A5 publication Critical patent/JP2009513555A5/ja
Application granted granted Critical
Publication of JP5052132B2 publication Critical patent/JP5052132B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006519892A 2003-07-15 2004-07-15 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法 Expired - Fee Related JP5052132B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0316546.1A GB0316546D0 (en) 2003-07-15 2003-07-15 Process for the manufacture of organic compounds
GB0316546.1 2003-07-15
PCT/EP2004/007980 WO2005014602A1 (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011104199A Division JP2011184451A (ja) 2003-07-15 2011-05-09 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法

Publications (3)

Publication Number Publication Date
JP2009513555A JP2009513555A (ja) 2009-04-02
JP2009513555A5 true JP2009513555A5 (https=) 2012-02-23
JP5052132B2 JP5052132B2 (ja) 2012-10-17

Family

ID=27763861

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006519892A Expired - Fee Related JP5052132B2 (ja) 2003-07-15 2004-07-15 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法
JP2011104199A Pending JP2011184451A (ja) 2003-07-15 2011-05-09 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011104199A Pending JP2011184451A (ja) 2003-07-15 2011-05-09 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法

Country Status (34)

Country Link
US (3) US7943647B2 (https=)
EP (2) EP2116548A1 (https=)
JP (2) JP5052132B2 (https=)
KR (5) KR20120018826A (https=)
CN (1) CN100475823C (https=)
AR (1) AR045995A1 (https=)
AT (1) ATE450541T1 (https=)
AU (1) AU2004263265C1 (https=)
BR (1) BRPI0412558A (https=)
CA (1) CA2532175A1 (https=)
CO (1) CO5670370A2 (https=)
CY (1) CY1109809T1 (https=)
DE (1) DE602004024402D1 (https=)
DK (1) DK1646636T3 (https=)
EC (2) ECSP066282A (https=)
ES (1) ES2336333T3 (https=)
GB (1) GB0316546D0 (https=)
HR (1) HRP20100088T1 (https=)
IL (2) IL172946A (https=)
IS (1) IS8303A (https=)
MA (1) MA27906A1 (https=)
MX (1) MXPA06000561A (https=)
MY (1) MY176840A (https=)
NO (1) NO20060729L (https=)
NZ (1) NZ544644A (https=)
PE (2) PE20091786A1 (https=)
PL (1) PL1646636T3 (https=)
PT (1) PT1646636E (https=)
RU (2) RU2006104322A (https=)
SI (1) SI1646636T1 (https=)
TN (1) TNSN06008A1 (https=)
TW (2) TWI372754B (https=)
WO (1) WO2005014602A1 (https=)
ZA (1) ZA200600312B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
JP4537678B2 (ja) * 2003-09-04 2010-09-01 住友化学株式会社 2’−(1h−テトラゾール−5−イル)ビフェニル−4−カルボアルデヒド結晶およびその製造方法
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan
GB0514206D0 (en) * 2005-07-11 2005-08-17 Novartis Ag Organic compounds
GB0514686D0 (en) * 2005-07-18 2005-08-24 Novartis Ag Organic compounds
WO2007020654A1 (en) * 2005-08-16 2007-02-22 Suven Life Sciences An improved process for the preparation of losartan
US7915425B2 (en) 2005-08-31 2011-03-29 Suven Life Sciences Limited Process for the preparation of losartan
KR100795589B1 (ko) * 2006-05-29 2008-01-21 주식회사 대희화학 2-부틸-4-클로로-1-[[2'-(1h-테트라졸-5-일)바이페닐-4-일]메틸]이미다졸-5-카르복스알데하이드의 제조방법
CN101200455B (zh) * 2007-09-29 2010-08-18 泰兴市江神化工有限公司 沙坦类治疗高血压药物主环5-(4'-甲酰基联苯-2-基)-1h-四氮唑的制备方法
US7932279B2 (en) 2007-10-12 2011-04-26 Arqule, Inc. Substituted tetrazole compounds and uses thereof
EP2316821A1 (en) 2009-10-27 2011-05-04 Novartis AG Process for the manufacture of organic compounds
JPWO2011061996A1 (ja) * 2009-11-17 2013-04-04 田辺三菱製薬株式会社 ビフェニル誘導体の製法
US10368340B2 (en) * 2010-04-01 2019-07-30 Hon Hai Precision Industry Co., Ltd. Network service exposure method and apparatus utilizing the same
KR101942064B1 (ko) * 2011-04-25 2019-01-24 주식회사 엘지화학 신규한 아연 아지드 착물 및 이를 이용한 테트라졸 유도체의 제조방법
CN102351804B (zh) * 2011-09-30 2013-07-31 浙江新赛科药业有限公司 一种缬沙坦消旋体的回收方法
CN102702117B (zh) * 2012-06-01 2016-04-13 浙江沙星医药化工有限公司 一种制备5-(4’-溴代甲基-2-联苯基)-1-三苯甲基四氮唑的方法
CN103265560B (zh) * 2013-05-17 2016-05-04 中国科学院上海高等研究院 棉酚/棉酮衍生物及其制备方法和抗肿瘤药物中的应用
KR101956281B1 (ko) * 2013-08-13 2019-03-08 삼성전기주식회사 수지 조성물, 이를 이용한 인쇄회로기판 및 그 제조방법
KR102090155B1 (ko) * 2019-11-22 2020-03-17 국방과학연구소 베타인 수용액 내에서 5-치환-1h-테트라졸의 제조방법
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers
CN116375687A (zh) * 2021-12-22 2023-07-04 浙江华海药业股份有限公司 一种高纯度的氯沙坦钾及其制备方法

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977372A (en) 1958-04-09 1961-03-28 William G Finnegan Process for preparing substituted tetrazoles
US3394142A (en) 1966-01-19 1968-07-23 Minnesota Mining & Mfg Substituted tetrazoles and process therefor
CH499526A (de) 1968-06-06 1970-11-30 Ciba Geigy Ag Verfahren zur Herstellung von neuen Tetrazolderivaten
SU497775A3 (ru) 1970-01-16 1975-12-30 Циба-Гейги Аг (Фирма) Способ получени производных тетразола
DE2650231A1 (de) 1976-11-02 1978-05-11 Hoechst Ag Neue imidazolverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4097479A (en) 1977-03-11 1978-06-27 Miles Laboratories, Inc. Synthesis of 5-substituted tetrazoles
US4122274A (en) 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4288352A (en) 1979-03-26 1981-09-08 Exxon Research & Engineering Co. Electrically conductive polymeric compositions
FI73423C (fi) * 1980-02-29 1987-10-09 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av farmakologiskt verksamma tetrazolderivat.
JPS56158781A (en) 1980-05-10 1981-12-07 Kaken Pharmaceut Co Ltd Tetrazolecoumarin derivative, its preparation and antiallergic agent containing the same as active constitutent
US4338452A (en) * 1980-09-17 1982-07-06 Eli Lilly And Company 1-and 2-(1-Alkyl-1H-tetrazol-5-yl-methyl)-1H-tetrazol-5-thiols and 1-cyanomethyl tetrazole-5-thiol
US4735948A (en) 1983-03-25 1988-04-05 Merrell Dow Pharmaceuticals Inc. (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
JPS6073028A (ja) 1983-09-29 1985-04-25 Japan Electronic Control Syst Co Ltd 電子制御燃料噴射式内燃機関の始動時の噴射量の学習制御装置
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB8708459D0 (en) 1987-04-09 1987-05-13 Avdel Ltd Fastener installation apparatus
US4820843A (en) 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4870186A (en) 1987-05-22 1989-09-26 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4874867A (en) 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4831192A (en) 1987-12-31 1989-05-16 Boc, Inc. Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5210079A (en) 1988-01-07 1993-05-11 E. I. Du Pont De Nemours And Company Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
US5128069A (en) * 1989-03-22 1992-07-07 Nippon Zoki Pharmaceutical Co., Ltd. Luciferin derivatives
IL97219A (en) * 1990-02-19 1995-12-08 Ciba Geigy Ag Biphenyl substituted aliphatic amino compounds process for their preparation and pharmaceutical compositions containing them
US5270317A (en) 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
TW201738B (https=) 1990-03-20 1993-03-11 Sanofi Co
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
JPH04297466A (ja) 1990-06-22 1992-10-21 Nippon Shinyaku Co Ltd テトラゾール誘導体及び医薬
US5284954A (en) 1990-09-10 1994-02-08 Abbott Laboratories Process for the preparation of tetrazoles
WO1992010189A1 (en) 1990-12-14 1992-06-25 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
US5594003A (en) 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5602127A (en) 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5614519A (en) 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
IE920540A1 (en) 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
JP2524842Y2 (ja) 1991-02-28 1997-02-05 三菱重工業株式会社 原紙供給装置
US5447949A (en) 1991-05-15 1995-09-05 Smithkline Beecham Corporation N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity
CA2115990A1 (en) 1991-08-19 1993-03-04 George Albert Boswell Angiotensin ii receptor blocking imidazolinone derivatives
AU657790B2 (en) 1991-08-22 1995-03-23 Warner-Lambert Company Amide tetrazole ACAT inhibitors
EP0550313A1 (fr) 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
WO1993014086A1 (en) 1992-01-17 1993-07-22 Syntex (U.S.A.) Inc. Substituted 1-isoquinolone derivatives as angiotensin ii antagonists
DE4203872A1 (de) * 1992-02-11 1993-08-12 Thomae Gmbh Dr K Imidazo(1,2-a)pyridine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4206045A1 (de) 1992-02-27 1993-09-02 Bayer Ag Sulfonylbenzyl substituierte pyridone
US5484955A (en) 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
JP2990566B2 (ja) * 1992-07-06 1999-12-13 武田薬品工業株式会社 トリ高級アルキルスズアジドおよびその用途
JPH06107658A (ja) 1992-09-28 1994-04-19 Kanebo Ltd 新規なピラジン誘導体
US5256658A (en) 1993-01-15 1993-10-26 Ortho Pharmaceutical Corporation Angiotensin II inhibitors
US5502191A (en) 1993-07-01 1996-03-26 American Cyanamid Company Method of synthesizing sterically hindered 5-substituted-1H-tetrazoles from nitriles using a lewis acid and an azide
WO1995017396A1 (en) 1993-12-23 1995-06-29 Merck & Co., Inc. Polymorphs of losartan and the process for the preparation of form ii of losartan
CN1043644C (zh) 1994-03-25 1999-06-16 默里尔药物公司 制备(1H-四唑-5-基)四唑并[1,5-a]喹啉和1,8-二氮杂萘的方法
EP0752990B1 (en) 1994-03-28 1998-08-05 Pfizer Inc. Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
US5541209A (en) 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
JPH08325248A (ja) 1995-05-26 1996-12-10 Chugoku Kayaku Kk テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
JP3671266B2 (ja) 1996-03-21 2005-07-13 東洋化成工業株式会社 5−置換テトラゾール類の製造方法
JPH10218868A (ja) 1997-02-12 1998-08-18 Toyo Kasei Kogyo Co Ltd 5ーメチルテトラゾールの製造方法
JP4450881B2 (ja) 1998-12-28 2010-04-14 株式会社日本ファインケム 5,5’−ビ−1h−テトラゾール塩の製造方法
JP2000281662A (ja) 1999-03-31 2000-10-10 Masuda Kagaku Kogyo Kk テトラゾール類の製造方法
DE19935219A1 (de) * 1999-07-27 2001-02-01 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
WO2001023442A1 (en) * 1999-09-27 2001-04-05 The Dow Chemical Company Supported catalyst comprising expanded anions
US20040072886A1 (en) * 2002-04-15 2004-04-15 Dr. Reddy's Laboratories Limited Novel crystalline forms of (S)-N- (1-Carboxy-2-methyl-prop-1-yl) -N-pentanoyl-N- [2' -(1H-tetrazol-5-yl)- biphenyl-4-yl methyl] amine (Valsartan)
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
US6934312B2 (en) * 2002-09-30 2005-08-23 Agilent Technologies, Inc. System and method for fabricating efficient semiconductor lasers via use of precursors having a direct bond between a group III atom and a nitrogen atom
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
CN100540541C (zh) * 2003-08-08 2009-09-16 迪法玛有限公司 制备苯基四唑衍生物的方法
US7445696B2 (en) 2004-03-17 2008-11-04 Kennecott Utah Copper Corporation Monitoring electrolytic cell currents

Similar Documents

Publication Publication Date Title
JP2009513555A5 (https=)
JP2011184451A5 (https=)
TWI679203B (zh) 製備抗病毒化合物之方法
TWI338003B (en) Process for the manufacture of organic compounds
JP2011184451A (ja) 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法
JP2017122107A (ja) チトクロームp450モノオキシゲナーゼの阻害剤およびそれに関わる中間体
Kitamura et al. Synthesis of primary amines and N-methylamines by the electrophilic amination of Grignard reagents with 2-imidazolidinone O-sulfonyloxime
KR100286874B1 (ko) 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
JP5035863B2 (ja) キノロン抗生物質中間体の調製方法
US11161851B2 (en) Processes to produce acalabrutinib
CN114127069A (zh) 苯酚衍生物的制造方法
KR20180050471A (ko) (s)-n1-(2-아미노에틸)-3-(4-알콕시페닐)프로판-1,2-디아민 3염산염의 제조방법
JPWO2021015109A5 (https=)
WO2004039785A1 (en) Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
JPS60258190A (ja) 新規なシクロトリシラザン
JP4108744B2 (ja) テトラゾールの製法
JP2022035954A (ja) N-Boc-ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法
JP7315805B1 (ja) 単環ピリジン誘導体の合成中間体の製造方法
WO2000026214A1 (en) Linear process for the preparation of a morpholine compound
JP6868890B2 (ja) 環上に置換基を有する含窒素環状化合物の製造方法
JP2022056770A (ja) アミン誘導体若しくはその塩、並びに、その塩及び環状アミン誘導体の製造方法
EP4378929A1 (en) Synthesis of aromatic boronic acids
KR101496681B1 (ko) N-치환된 3,3-디니트로아제티딘 고에너지 가소제 및 그의 제조방법
CN119948011A (zh) 烷基甲硅烷氧基取代苄胺化合物的制造方法
JP2565710B2 (ja) アゾグアニル化合物塩酸塩の製造法